Scarica l'app Stockscreener
48.24
1.31%
0.625
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RVMD Giù?
Forum
Previsione
Precedente Chiudi:
$47.62
Aprire:
$47.64
Volume 24 ore:
2.49M
Relative Volume:
1.31
Capitalizzazione di mercato:
$9.02B
Reddito:
$29.52M
Utile/perdita netta:
$-567.06M
Rapporto P/E:
-13.18
EPS:
-3.66
Flusso di cassa netto:
$-551.11M
1 W Prestazione:
+3.28%
1M Prestazione:
+19.26%
6M Prestazione:
+43.27%
1 anno Prestazione:
-2.55%
Intervallo 1D:
$47.28
$49.10
Intervallo di 1 settimana:
$45.80
$49.50
Portata 52W:
$29.17
$62.40
Revolution Medicines Inc Stock (RVMD) Company Profile
Nome
Revolution Medicines Inc
Settore
Industria
Telefono
415-766-3638
Indirizzo
700 SAGINAW DR, REDWOOD CITY, CA
Confronta RVMD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RVMD
Revolution Medicines Inc
|
48.24 | 8.90B | 29.52M | -567.06M | -551.11M | -3.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Revolution Medicines Inc Stock (RVMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-12 | Ripresa | Raymond James | Strong Buy |
| 2025-09-05 | Iniziato | Truist | Buy |
| 2025-08-19 | Iniziato | Piper Sandler | Overweight |
| 2025-08-15 | Iniziato | Wells Fargo | Overweight |
| 2025-07-15 | Iniziato | Goldman | Buy |
| 2024-07-16 | Reiterato | Needham | Buy |
| 2024-07-12 | Iniziato | Barclays | Overweight |
| 2024-07-08 | Iniziato | Jefferies | Buy |
| 2024-04-12 | Reiterato | Needham | Buy |
| 2024-04-10 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-03-11 | Iniziato | Piper Sandler | Overweight |
| 2024-01-05 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-01-04 | Iniziato | Wedbush | Outperform |
| 2023-11-16 | Iniziato | Raymond James | Outperform |
| 2023-02-28 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-12-14 | Iniziato | Needham | Buy |
| 2022-10-21 | Iniziato | Oppenheimer | Outperform |
| 2022-05-20 | Iniziato | BofA Securities | Neutral |
| 2022-03-01 | Aggiornamento | Stifel | Hold → Buy |
| 2021-09-23 | Iniziato | Stifel | Hold |
| 2021-08-12 | Downgrade | Goldman | Buy → Neutral |
| 2021-05-18 | Iniziato | Goldman | Buy |
| 2020-05-21 | Iniziato | H.C. Wainwright | Buy |
| 2020-03-09 | Iniziato | Cowen | Outperform |
| 2020-03-09 | Iniziato | Guggenheim | Buy |
| 2020-03-09 | Iniziato | JP Morgan | Neutral |
Mostra tutto
Revolution Medicines Inc Borsa (RVMD) Ultime notizie
How sentiment analysis helps forecast Revolution Medicines Inc. Equity Warrant - newser.com
How analysts rate Revolution Medicines Inc. stock todayWeekly Risk Report & Entry and Exit Point Strategies - newser.com
How high can Revolution Medicines Inc. Equity Warrant stock goPortfolio Return Summary & High Conviction Investment Ideas - newser.com
What recovery options are there for Revolution Medicines Inc.2025 AllTime Highs & Detailed Earnings Play Alerts - newser.com
Can technical indicators confirm Revolution Medicines Inc.’s reversalTrade Exit Summary & AI Powered Buy/Sell Recommendations - newser.com
Why Revolution Medicines Inc. Equity Warrant stock appeals to dividend seekersOptions Play & Long-Term Capital Growth Ideas - newser.com
Using data models to predict Revolution Medicines Inc. stock movementQuarterly Profit Review & Real-Time Buy Signal Notifications - newser.com
Should you wait for a breakout in Revolution Medicines Inc. Equity WarrantGap Up & Community Shared Stock Ideas - newser.com
How Revolution Medicines Inc. stock performs in interest rate cycles2025 Volume Leaders & Verified Momentum Stock Watchlist - newser.com
Revolution Medicines Inc. Equity Warrant stock volume spike explained2025 Volume Leaders & High Conviction Investment Ideas - newser.com
Revolution Medicines (NASDAQ:RVMD) Earns "Sell (D-)" Rating from Weiss Ratings - MarketBeat
How analysts revise price targets for Revolution Medicines Inc. (42Z) stockJuly 2025 Market Mood & Community Consensus Stock Picks - newser.com
What recovery options are there for Revolution Medicines Inc. Equity WarrantQuarterly Portfolio Summary & Low Volatility Stock Recommendations - newser.com
Revolution Medicines’ SWOT analysis: RAS inhibitor stock poised for growth amid fierce competition - Investing.com
Revolution Medicines’ SWOT analysis: RAS inhibitor stock poised for growth amid fierce competition By Investing.com - Investing.com South Africa
What analysts say about Revolution Medicines Inc stockTrendline Breakouts & Explosive Growth Opportunities - earlytimes.in
Did Leadership Moves Just Shift Revolution Medicines' (RVMD) Investment Narrative Ahead of Key Launches? - Yahoo Finance
Is now a turning point for Revolution Medicines Inc. Equity WarrantJuly 2025 Spike Watch & Low Volatility Stock Recommendations - newser.com
Assessing Revolution Medicines After Recent Cancer Breakthrough and 15% Monthly Rally - Yahoo Finance
Real time breakdown of Revolution Medicines Inc. stock performance2025 Technical Overview & Real-Time Stock Movement Alerts - newser.com
Using fundamentals and technicals on Revolution Medicines Inc. Equity WarrantTrade Signal Summary & Daily Profit Maximizing Tips - newser.com
How hedge fund analytics apply to Revolution Medicines Inc. stockQuarterly Earnings Report & Risk Managed Investment Entry Signals - newser.com
Short interest data insights for Revolution Medicines Inc.Weekly Investment Summary & High Accuracy Swing Trade Signals - newser.com
Evaluating Revolution Medicines Inc. with trendline analysisPortfolio Return Report & Stock Portfolio Risk Management - newser.com
Multi factor analysis applied to Revolution Medicines Inc. Equity WarrantTreasury Yields & Proven Capital Preservation Tips - newser.com
Will Revolution Medicines Inc. stock go up soon2025 Retail Activity & Weekly High Momentum Picks - newser.com
Will Revolution Medicines Inc. Equity Warrant stock benefit from upcoming earnings reportsBreakout Watch & Risk Controlled Stock Pick Alerts - newser.com
Advanced analytics toolkit walkthrough for Revolution Medicines Inc. Equity WarrantMarket Sentiment Review & Real-Time Stock Price Movement Reports - newser.com
Will Revolution Medicines Inc. Equity Warrant price bounce be sustainable2025 Top Gainers & Reliable Price Breakout Alerts - newser.com
Is Revolution Medicines Inc. stock vulnerable to regulatory risksSwing Trade & Reliable Volume Spike Trade Alerts - newser.com
Long term hold vs stop loss in Revolution Medicines Inc. Equity WarrantMarket Risk Analysis & Growth Oriented Trade Recommendations - newser.com
Published on: 2025-10-05 02:52:08 - newser.com
Will Revolution Medicines Inc. Equity Warrant outperform the marketEarnings Beat & Weekly High Conviction Trade Ideas - newser.com
Revolution Medicines, Inc. (NASDAQ:RVMD) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Sentiment analysis tools applied to Revolution Medicines Inc.Market Trend Summary & Verified Entry Point Detection - newser.com
Regression analysis insights on Revolution Medicines Inc. Equity Warrant performanceWeekly Trading Summary & Risk Managed Investment Strategies - newser.com
Public Employees Retirement System of Ohio Makes New $1.98 Million Investment in Revolution Medicines, Inc. $RVMD - MarketBeat
What moving averages say about Revolution Medicines Inc.Trend Reversal & Low Volatility Stock Recommendations - newser.com
Published on: 2025-10-03 01:48:18 - newser.com
Revolution Medicines Inc Azioni (RVMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):